Rovin Capital’s American Renal Associates Holdings ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-34,000
Closed -$389K – 53
2020
Q4
$389K Hold
34,000
– – 0.31% 26
2020
Q3
$235K Hold
34,000
– – 0.22% 30
2020
Q2
$222K Hold
34,000
– – 0.23% 31
2020
Q1
$245K Hold
34,000
– – 0.26% 30
2019
Q4
$353K Buy
+34,000
New +$291K 0.31% 29

Rovin Capital's ARA Position: Q1 2021 in Review

Rovin Capital sold out of American Renal Associates Holdings (ARA) in Q1 2021, closing a stake of 34,000 shares — an estimated $389K sold.

Rovin Capital first reported a position in ARA in Q4 2019 and held it in 5 quarters. The position peaked at $389K in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Rovin Capital reported no remaining American Renal Associates Holdings position as of Q1 2021 after selling out during the quarter.
  • Rovin Capital sold 34,000 American Renal Associates Holdings shares in Q1 2021, an estimated $389K.
  • Rovin Capital first reported a position in American Renal Associates Holdings in Q4 2019 and held it in 5 quarters.
  • Rovin Capital's American Renal Associates Holdings position peaked at $389K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings as of Q1 2021.

Based on Rovin Capital's 13F filing for Q1 2021, filed 8 Apr 2021.